Clinical Trial Update: A Safety and Efficacy Comparison of BLI4700 Bowel Prep Versus an FDA-approved Comparator in Adults Prior to Colonoscopy [Phase 3]

View source ↗

Summary

Phase 3 trial comparing BLI4700 bowel prep to an FDA-approved comparator in adults undergoing colonoscopy has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colonoscopy-related Procedures

Drugs mentioned

• BLI4700 (BLI4700)

Snippet

Sponsor: Braintree Laboratories | Conditions: Colonoscopy | Phase 3 | Status: COMPLETED | Results posted: 2021-09-08